May 21, 2025 | 8:00 PM JST / 7:00 AM EDT
This session is designed to guide biotech founders—especially those navigating both the Japanese and U.S. markets—through strategic funding decisions that shape early-stage growth. Learn the differences between dilutive and non-dilutive funding, how investors in both countries evaluate startups, and how to position your company for global funding success. Attendees will walk away with a clear roadmap to structure their capital strategy for international competitiveness.

Coming December 2025
From choosing the right entity structure to planning for exit strategies and forging international partnerships, this webinar will explore how biotech founders can position their companies for success across borders. With a focus on both the Japanese and U.S. biotech markets, the session will provide actionable guidance on corporate formation, identifying strategic partners, and creating a scalable growth plan for global impact

Coming May 2026
This session explores the critical decisions behind team-building at early-stage biotech companies. From the transition between scientific founders and professional CEOs to strategies for recruiting and retaining top talent, this webinar will offer insights into assembling leadership that can take your company to the next level. With input from leaders in both Japan and the U.S., attendees will learn how to shape high-performance teams that can thrive in global biotech markets.

Coming September 2026
Global biotech companies must master regulatory complexity. This webinar compares key differences between Japan’s PMDA and the U.S. FDA, offering insights into how each system impacts clinical development, approval timelines, and commercialization. Learn how to use a Target Product Profile (TPP) to guide regulatory and clinical strategy and ensure alignment with global standards—essential knowledge for companies operating in both markets.